CVC Capital Partners, a private equity and investment advisory firm, completed the acquisition of a majority stake in Rayner, a provider of optical instruments, from Phoenix Equity Partners, a UK-based private equity firm. Financial terms were not disclosed. “Having recently tripled our manufacturing capacity and strengthened our R&D capability, we are primed to embark on our next phase of growth and improve outcomes for even more patients with our world-class implants and treatments for a broad range of ophthalmic conditions. With its extensive healthcare experience, CVC understands our business and supports our ambition to become an international ophthalmology leader," Tim Clover, Rayner CEO.